tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CDTX Stock Latest News

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Press ReleasesCidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
14d ago
CDTX
Cidara Therapeutics CEO buys $105.7K in common stock
PremiumThe Fly
Cidara Therapeutics CEO buys $105.7K in common stock
1M ago
CDTX
Cidara Therapeutics to Present Preclinical Data on CD388 at ASM Microbe 2024 Conference
PremiumPress Releases
Cidara Therapeutics to Present Preclinical Data on CD388 at ASM Microbe 2024 Conference
2M ago
CDTX
Cidara Therapeutics Inc. Hits Snag: Delayed 10-K Filing Complicates Capital Raising Efforts
PremiumCompany Announcements
Cidara Therapeutics Inc. Hits Snag: Delayed 10-K Filing Complicates Capital Raising Efforts
2M ago
CDTX
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
PremiumPress Releases
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
2M ago
CDTX
Cidara Therapeutics Regains Compliance with Nasdaq Continued Listing Rules
PremiumPress ReleasesCidara Therapeutics Regains Compliance with Nasdaq Continued Listing Rules
2M ago
CDTX
Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024
PremiumPress Releases
Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024
3M ago
CDTX
Cidara Therapeutics announces presentations on CD388 data
PremiumThe Fly
Cidara Therapeutics announces presentations on CD388 data
3M ago
CDTX
Cidara Therapeutics rating placed under review at H.C. Wainwright
PremiumThe Fly
Cidara Therapeutics rating placed under review at H.C. Wainwright
3M ago
CDTX
Cidara Therapeutics Refocuses Strategy with Asset Sale
PremiumCompany Announcements
Cidara Therapeutics Refocuses Strategy with Asset Sale
3M ago
8K
CDTX
Cidara Therapeutics: Strategic Partnerships and Governance Changes
PremiumCompany Announcements
Cidara Therapeutics: Strategic Partnerships and Governance Changes
3M ago
8K
CDTX
Cidara Therapeutics reacquires rights to CD388 from Johnson & Johnson for $85M
PremiumThe Fly
Cidara Therapeutics reacquires rights to CD388 from Johnson & Johnson for $85M
3M ago
JNJ
CDTX
Cidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipeline
PremiumPress ReleasesCidara Therapeutics Announces Divestiture of Rezafungin to Mundipharma* to Focus on Advancing the Clinical Development of Cloudbreak DFC Pipeline
3M ago
CDTX
Cidara Therapeutics divests rezafungin to Mundipharma
PremiumThe Fly
Cidara Therapeutics divests rezafungin to Mundipharma
3M ago
CDTX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
ASLN
CDTX
Cidara Therapeutics’ Restatement Woes: Costs, Distractions, and Investor Confidence on the Line
PremiumCompany Announcements
Cidara Therapeutics’ Restatement Woes: Costs, Distractions, and Investor Confidence on the Line
3M ago
CDTX
Cidara Therapeutics trading halted, news pending
PremiumThe Fly
Cidara Therapeutics trading halted, news pending
3M ago
CDTX
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
3M ago
CDTX
Cidara Therapeutics reports Q4 EPS (4c), consensus (10c)
PremiumThe Fly
Cidara Therapeutics reports Q4 EPS (4c), consensus (10c)
3M ago
CDTX
Cidara Therapeutics Announces Receipt of Nasdaq Delinquency Notice
PremiumPress ReleasesCidara Therapeutics Announces Receipt of Nasdaq Delinquency Notice
3M ago
CDTX
Cidara Therapeutics discloses Nasdaq listing deficiency notice
PremiumThe Fly
Cidara Therapeutics discloses Nasdaq listing deficiency notice
3M ago
CDTX
Cidara Therapeutics announces 1-for-20 reverse stock split
PremiumThe Fly
Cidara Therapeutics announces 1-for-20 reverse stock split
3M ago
CDTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >